Share on StockTwits

Shire PLC (NASDAQ:SHPGY)‘s stock had its “buy” rating restated by research analysts at Jefferies Group in a report released on Tuesday.

Other equities research analysts have also recently issued reports about the stock. Analysts at Susquehanna raised their price target on shares of Shire PLC from $220.00 to $260.00 in a research note on Friday. They now have a “positive” rating on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Shire PLC in a research note on Tuesday, June 17th. Finally, analysts at Barclays reiterated an “overweight” rating on shares of Shire PLC in a research note on Wednesday, May 21st. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $260.00.

Shire plc (NASDAQ:SHPGY) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.